申请人:SHIONOGI & CO., LTD.
公开号:EP1219607A1
公开(公告)日:2002-07-03
A compound of the formula (I):
wherein
X is hydroxy or the like;
Y is -C(=R2)-R3-R4 wherein R2 and R3 is oxygen atom or the like, R4 is hydrogen, optionally substituted alkyl,
optionally substituted heteroaryl or the like;
Z is hydrogen or the like;
Z1 and Z3 each is independently a bond, alkylene or the like;
Z2 is a bond, alkylene, -O- or the like;
R1 is optionally substituted aryl, optionally substituted heteroaryl or the like;
p is 0 to 2 and
ring (A) is optionally substituted aromatic heterocycle, a tautomer of itself, a prodrug thereof, a pharmaceutically acceptable salt thereof or a solvate thereof has an integrase-inhibiting activity.
式 (I) 的化合物:
其中
X 是羟基或类似物
Y 是-C(=R2)-R3-R4,其中 R2 和 R3 是氧原子或类似物,R4 是氢、任选取代的烷基、任选取代的杂芳基或类似物; Y 是-C(=R2)-R3-R4、
任选取代的杂芳基或类似物;
Z 是氢或类似物;
Z1 和 Z3 各自独立地是键、亚烷基或类似物;
Z2 是键、亚烷基、-O- 或类似物;
R1 是任选取代的芳基、任选取代的杂芳基或类似物;
p 为 0 至 2,且
环(A)是任选取代的芳香杂环,其本身、其原药、其药学上可接受的盐或其溶液的同系物具有整合酶抑制活性。